Anavex Life Sciences (AVXL)
(Delayed Data from NSDQ)
$6.50 USD
-0.09 (-1.29%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $6.50 +0.01 (0.08%) 6:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Anavex Life Sciences Corp. [AVXL]
Reports for Purchase
Showing records 81 - 100 ( 157 total )
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
BUY: DSMB Rett Syndrome Study Should Continue: No Change
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
BUY: DSMB - Alzheimer''s Study Should Continue: No Change
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Alzheimer''s Disease Phase 2/3 Trial Continuation Recommended; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
BUY: We See ANAVEX2-73 as an Undervalued Asset in the CNS Space ? Alzheimer''s, Raising Our Price Target to $19.00 from $16.00
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
F1Q21 Financial Results; Lengthy Cash Runway; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Recent Stock Appreciation May Portend Further Value Inflection; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Fiscal 2020 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Blarcamesine Positive Phase 2 Rett Syndrome Data; Raising PT to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Recent Patent Allowance Could Extend Exclusivity; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Phase 2 Parkinson''s Disease Data Indicates Path Forward; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Positive Phase 2 Parkinson''s Disease Data; Raising PT to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
BUY: Anavex2-73 Phase 2 Trial Demonstrates Proof of Concept
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Parkinson''s Dementia Data Imminent; F3Q20 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Second Pipeline Candidate Enters Clinical Development; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Excellent. Anavex2-73 Enrolls First Phase 2/3 Patient in Rett Syndrome (EXCELLENCE) Trial
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
BUY: Anavex2-73 Exceeds Enrollment Target in Rett Syndrome Trial
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Enrollment Target Substantially Exceeded in Rett Syndrome Phase 2 Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Alzheimer''s Disease Trial Geographic Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R